S&P 500   3,984.74 (+0.12%)
DOW   31,631.55 (+0.16%)
QQQ   298.77 (-0.07%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,984.74 (+0.12%)
DOW   31,631.55 (+0.16%)
QQQ   298.77 (-0.07%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,984.74 (+0.12%)
DOW   31,631.55 (+0.16%)
QQQ   298.77 (-0.07%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,984.74 (+0.12%)
DOW   31,631.55 (+0.16%)
QQQ   298.77 (-0.07%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
OTCMKTS:INLX

Intellinetics - INLX Stock Forecast, Price & News

$6.25
+1.29 (+26.01%)
(As of 09/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.99
$6.35
50-Day Range
$3.76
$6.25
52-Week Range
$3.76
$9.90
Volume
7,703 shs
Average Volume
383 shs
Market Capitalization
$17.69 million
P/E Ratio
14.20
Dividend Yield
N/A
Price Target
N/A
INLX stock logo

About Intellinetics (OTCMKTS:INLX) Stock

Intellinetics, Inc. designs, develops, tests, markets, and licenses document services and software solutions in the United States. The company operates in two segments, Document Management and Document Conversion. Its software platform allows its customers to capture and manage documents across operations, such as scanned hard-copy documents and digital documents, including Microsoft Office 365, digital images, audios, videos, and emails. The company's flagship software suite includes IntelliCloud platform that comprises image processing modules, records management, workflow, and extended components. It also provides installation, integration, training, and consulting services; ongoing software maintenance and customer support services; and digital scanning, microfilm and microfiche, box storage, scanning equipment, and software and repair services, as well as long-term paper and microfilm storage, and retrieval option services. In addition, the company offers business process outsourcing services. Intellinetics, Inc. sells its products to resellers and directly to customers, as well as provides access to its software solutions as a service through the Internet. It serves business and federal, county, and municipal governments, as well as healthcare, K-12 education, public safety, other public sector, risk management, financial services, and others. The company was formerly known as GlobalWise Investments, Inc. and changed its name to Intellinetics, Inc. in September 2014. Intellinetics, Inc. was incorporated in 1996 and is headquartered in Columbus, Ohio.

Receive INLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

INLX Stock News Headlines

Intellinetics Announces Rescheduling of Annual Meeting
Intellinetics, Inc. Reports Second Quarter Results
DHI Group (DHX) Meets Q2 Earnings Estimates
Here's what Wall Street expects from Intellinetics's earnings report
INLX Pre-Market Quotes
INLX Real-Time Quotes
See More Headlines
Receive INLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

INLX Company Calendar

Last Earnings
11/15/2021
Today
9/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
OTCMKTS:INLX
Fax
N/A
Employees
93
Year Founded
N/A

Profitability

Net Income
$1.36 million
Pretax Margin
-0.59%

Debt

Sales & Book Value

Annual Sales
$11.46 million
Cash Flow
$0.82 per share
Book Value
$0.94 per share

Miscellaneous

Free Float
2,579,000
Market Cap
$17.69 million
Optionable
Not Optionable
Beta
0.36

Key Executives

  • Mr. James F. DeSocio (Age 67)
    Pres, CEO & Director
    Comp: $276.67k
  • Mr. Joseph D. Spain (Age 54)
    CFO & Treasurer
    Comp: $168.82k
  • Mr. Matthew L. Chretien (Age 54)
    Chief Strategy Officer, CTO, Sec. & Director
    Comp: $190.78k
  • Ryan Bell
    Chief Technology Officer
  • Ms. Tessa Tyler
    Chief Education Officer













INLX Stock - Frequently Asked Questions

How have INLX shares performed in 2022?

Intellinetics' stock was trading at $7.56 on January 1st, 2022. Since then, INLX stock has decreased by 17.3% and is now trading at $6.25.
View the best growth stocks for 2022 here
.

How were Intellinetics' earnings last quarter?

Intellinetics, Inc. (OTCMKTS:INLX) released its earnings results on Monday, November, 15th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.09. The business had revenue of $3.17 million for the quarter, compared to the consensus estimate of $2.79 million. Intellinetics had a negative trailing twelve-month return on equity of 1.81% and a negative net margin of 0.60%.

What other stocks do shareholders of Intellinetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?

Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."

How do I buy shares of Intellinetics?

Shares of INLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intellinetics' stock price today?

One share of INLX stock can currently be purchased for approximately $6.25.

How much money does Intellinetics make?

Intellinetics (OTCMKTS:INLX) has a market capitalization of $17.69 million and generates $11.46 million in revenue each year. The company earns $1.36 million in net income (profit) each year or $0.44 on an earnings per share basis.

How can I contact Intellinetics?

Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The official website for the company is www.intellinetics.com. The company can be reached via phone at (614) 921-8170 or via email at contactus@intellinetics.com.

This page (OTCMKTS:INLX) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.